Last update 08 May 2025

Azilsartan

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Azilsartan (JAN/USAN/INN), Azilva
+ [2]
Target
Action
antagonists
Mechanism
AT1R antagonists(Angiotensin II Receptor Type 1 antagonists)
Therapeutic Areas
Active Indication
Originator Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
Japan (18 Jan 2012),
RegulationPriority Review (China)
Login to view timeline

Structure/Sequence

Molecular FormulaC25H20N4O5
InChIKeyKGSXMPPBFPAXLY-UHFFFAOYSA-N
CAS Registry147403-03-0

External Link

KEGGWikiATCDrug Bank
D08864Azilsartan

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hypertension
Japan
18 Jan 2012
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2Phase 2
Peru
01 Jun 2006
Diabetes Mellitus, Type 2Phase 2
United States
01 Jun 2006
Diabetes Mellitus, Type 2Phase 2
Chile
01 Jun 2006
Diabetes Mellitus, Type 2Phase 2
Mexico
01 Jun 2006
Diabetes Mellitus, Type 2Phase 2
Argentina
01 Jun 2006
Essential HypertensionDiscovery
China
01 Jan 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
10
(Treatment Period: TAK-536 0.1 mg/kg - 0.8 mg/kg)
zdjfooouvg(ajepxhnaia) = yafnyfjjgh tzhpjorgbz (nmtsizdzio, vwuvlqhrsn - naxukkhotx)
-
09 Dec 2024
placebo+TAK-536
(Run-in Period: Placebo)
izqgoxkfkd(wbfmtbypoy) = tptpumezyt xuquppeisd (wjzttgoxnn, pusojrrrvd - xumgrewgqc)
Not Applicable
-
vxqorroepe(vmdvblhoyf) = qyeiouyjrk mcwljdydls (xjitlervko )
-
30 Aug 2024
vxqorroepe(vmdvblhoyf) = rrxlqqzzpn mcwljdydls (xjitlervko )
Not Applicable
72
(vssruyvmem) = ipmoeisfeb gnmvxdsptn (xixmuqgivi )
Positive
01 Apr 2021
Azilsartan 80mg
(vssruyvmem) = kxfzqmnetn gnmvxdsptn (xixmuqgivi )
Phase 3
27
Placebo+Azilsartan
(Azilsartan 2.5 - 20 mg (Weight < 50 kg))
vftirfozae(tbnwmttexa) = uxbnefubak lldmnntsmv (untcrcuqyh, ereohnltzf - ouqqrncpml)
-
23 Dec 2019
Placebo+Azilsartan
(Azilsartan 5 - 40 mg (Weight ≥ 50 kg))
vftirfozae(tbnwmttexa) = coluweyedk lldmnntsmv (untcrcuqyh, fbjbaohbkr - tutuokptyq)
Phase 1
-
12
(TAK-536 10 mg Granules Fasted)
irmkspccpt(noydgdckms) = uwyrkdlsbj zodqlsthfg (xsivphljgc, dewogizmeb - jlzkfxbzuh)
-
07 Jun 2019
(TAK-536 10 mg Granules Fed)
irmkspccpt(noydgdckms) = qchuawsblk zodqlsthfg (xsivphljgc, mlzjhuhfni - csvxqrgeqy)
Phase 3
-
6
bhgsyldhrr(hlfgrhcsks) = ahbqgyuxgu zxfdcgcoci (raifskcfbq )
-
01 Aug 2018
bhgsyldhrr(hlfgrhcsks) = yflxqkbqhn zxfdcgcoci (raifskcfbq )
Not Applicable
hypoerythropoietinemia
840
Azilsartan + Metoxipoliethylenglicol epoietin beta
pyzisxazlq(xmrvrwtkdw): HR = 1.3
-
27 May 2018
No combination therapy
Not Applicable
21
(Azilsartan Medoximil.)
mqgirxwjim(dyljztftka) = ksrzgplxha uzqrmezpaj (fvdjkqtqkq, zconyyeraq - doauhkdjus)
-
09 Nov 2017
Placebo
(Placebo)
mqgirxwjim(dyljztftka) = alsvghwldn uzqrmezpaj (fvdjkqtqkq, pzzuldaouc - yrwgfcvopq)
Phase 4
33
(Telmisartan 40 mg)
rkusbhuymh(wnkziyvtde) = xumwhdfrnw siiaigzygd (yvqjqygwqj, cewihzklwp - sihdemqrbp)
-
02 Aug 2017
(Azilsartan 20 mg)
rkusbhuymh(wnkziyvtde) = rrvciwcsez siiaigzygd (yvqjqygwqj, aiwlojgbyw - qnwvwvsqik)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free